1. MARKETS
  2. SECTOR : BANKING AND FINANCE
  3. INDUSTRY : FINANCE (INCLUDING NBFCS)
  4. TRINITY BIO-TECH LTD.
Trinity Bio-Tech Ltd.
BSE: 530573
Ask AI about Trinity Bio-Tech

Portfolio

Alert

My Notes

Trinity Bio-Tech quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Trinity Bio-Tech quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue Trinity Bio-Tech Mar-2009 Quarterly Revenue is Rs 0 Cr which is growth of 0% YoY.

  • NEUTRAL

    Quarterly Net Profit Trinity Bio-Tech Mar-2009 Quarterly Net Profit is Rs 0 Cr which is growth of 0% YoY.

Trinity Bio-Tech Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphDec '07Sep '07Jun '07Mar '07Dec '06Sep '06Jun '06Mar '06Dec '05Sep '05Jun '05Mar '05Dec '04
⌄
0.100.10.10.10.10.10.10.10.1
Operating Exp.
00.310.50.40.40.30.30.30.30.2
Operating Profit
0.1-0.3-1-0.4-0.3-0.3-0.3-0.3-0.2-0.2-0.2
Operating Profit Margin %
--94.89%---408.99%-408.64%-406.76%-407.46%-408.20%-412.73%-456.52%-454.76%
Depr.
0.10.10.60.50.50.40.40.40.30.3
Interest
-0.200000000
Profit Before Tax
0.1-0.2-1-1-0.9-0.8-0.7-0.7-0.6-0.6-0.5
Tax
0
Net Profit
0.1-0.2-1-1-0.9-0.8-0.7-0.7-0.6-0.6-0.5
EPS Adj. latest
-------------
Net profit TTM
-0.1-1.1-2-3-3.7-3.4-3.1-2.8-2.6-2.3-2.1-1.9-1.8
Basic EPS TTM
-0.3-3.2-6.2-9.1-11-10.2-9.3-8.4-7.7-7-6.4-5.8-5.3
*All financials are in INR Cr and price data in INR

Trinity Bio-Tech competitor comparison and performance snapshot within industry

Trinity Bio-Tech annual results: revenue, profit, P&L, and margins as of Mar 2009 – 11 year history

  • NEGATIVE

    Annual Revenue Trinity Bio-Tech Annual Revenue is Rs 0 Cr which is growth of -29.6% YoY.

  • POSITIVE

    Annual Net Profit Trinity Bio-Tech Annual Net Profit is Rs -0 Cr which is growth of 98.7% YoY.

Trinity Bio-Tech Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsTTMMar '09Mar '08Mar '07Mar '06Mar '04
-20.6%
0.20.20.20.20.41
Operating Exp. Ann.
242%
0.343.20.30.10.8
Operating Profit Ann.
-
-0.2-4-3.2-0.3-00.1
OPM Ann. %
-
 -2,355.96%-1,321.51%-138.49%-5.03%11.58%
⌄
242%
 43.20.40.11.2
EBITDA Ann.
-
 -3.8-2.9-0.10.30.1
EBITDA Ann. margin %
-
 -2,255.96%-1,221.52%-58.38%84.09%13.68%
Interest Ann.
-
-0.200.1
Depr.
-
0.10.10.10.3
PBT Ann.
-
-0-3.8-3-0.20.2-0.2
Tax Ann.
-
0
-
 -3.8-3-0.20.2-0.2
Net Profit Ann.
-
-0.1-0-1.8-0.20.2-0.2
NPM Ann. %
-
 -460.32%605.24%-22.58%
EPS Adj. latest Ann.
-
 -----
*All financials are in INR Cr and price data in INR
Total Rev. Ann.
3Y CAGR
-20.6%
5Y CAGR
-27.5%
Operating Exp. Ann.
1Y CHG
25%
2Y CAGR
265.1%
3Y CAGR
242%
5Y CAGR
38%

Trinity Bio-Tech balance sheet as of Mar 2009: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Trinity Bio-Tech Total Shareholders Fund is Rs -2 Cr which is growth of -1.3% YoY.

  • NEGATIVE

    Total Assets Trinity Bio-Tech Total Assets is Rs 9 Cr which is growth of -25.9% YoY.

Trinity Bio-Tech Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsMar '09Mar '08Mar '07Mar '06Mar '04
⌄
-
-1.8-1.800.2-0.1
Minority Interest Liability Ann.
-
-----
⌄
2.6%
10.810.210.2108.8
-
03.95.75.16.5
Total Capital Plus Liabilities Ann.
-15.9%
9.112.31615.315.1
⌄
-
000.40.6
⌄
-28.9%
0.90.92.12.51.8
-13.8%
8.211.413.912.813.3
Total Assets Ann.
-15.9%
9.112.31615.315.1
Contingent Liabilities plus Commitments Ann.
-
Bonus Equity Share Capital Ann.
0%
0.50.50.50.5
Non Current Investments Unquoted Book Value Ann.
-53.6%
0.10.111
Current Investments Unquoted Book Value Ann.
-
*All financials are in INR Cr and price data in INR
Total Assets Ann.
1Y CHG
-26%
2Y CAGR
-24.6%
3Y CAGR
-15.9%
5Y CAGR
-9.6%

Trinity Bio-Tech ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2009 – 11 year history

  • NEGATIVE

    Book Value Per Share Trinity Bio-Tech Book Value Per Share is -5 Rs which is growth of -1.3% YoY.

  • POSITIVE

    ROE Trinity Bio-Tech ROE is 1% which is growth of 100.8% YoY.

Trinity Bio-Tech Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsMar '09Mar '08Mar '07Mar '06Mar '04
BVSH Ann.
-
-5.3-5.30.10.6-0.4
RoA Ann. %
-
-0.25%-14.58%-1.07%1.59%-1.39%
ROE Ann. %
-77.7%
1.30%102.08%-468.15%117.32%175.00%
ROCE Ann. %
-
-0.25%-21.29%-1.66%2.39%-2.43%
⌄
-
     
⌄
-
     
⌄
-
     
Total Debt to Total Equity Ann.
-
-6.1-5.828048-72.9
*All financials are in INR Cr and price data in INR
ROE Ann. %
1Y CHG
-98.7%
3Y CAGR
-77.7%
5Y CAGR
-62.5%
Current Ratio Ann.
1Y CHG
10672.4%
2Y CAGR
1040.9%
3Y CAGR
399.9%
5Y CAGR
172%

Trinity Bio-Tech cash flow: net, operating, investing, and financing flows as of Mar 2009 – 11 year history

  • NEUTRAL

    Cash From Operating Activity Trinity Bio-Tech Cash From Operating Activity is Rs 0 Cr which is growth of 0% YoY.

  • NEUTRAL

    Net Cash Flow Trinity Bio-Tech Net Cash Flow is Rs 0 Cr which is growth of 0% YoY.

Trinity Bio-Tech Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
IndicatorGraphCAGR 3 YrsMar '09Mar '08Mar '07Mar '06Mar '04
-
-0.6
Cash from Investing Act. Ann.
-
0.4
Cash from Financing Act. Ann.
-
0.3
-
*All financials are in INR Cr and price data in INR

Trinity Bio-Tech investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access